Ovarian hyperstimulation

From WikiMD's Medical Encyclopedia

Revision as of 13:19, 14 July 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Ovarian Hyperstimulation Syndrome (OHSS) is a medical condition that can occur in some women who are undergoing fertility treatment. It is characterized by the ovaries becoming swollen and painful after taking injectable hormone medications to stimulate the development of eggs in the ovaries. These medications, which include Follicle Stimulating Hormone (FSH) and Human Chorionic Gonadotropin (hCG), can lead to an exaggerated response from the ovaries, resulting in the production of too many eggs. OHSS is classified into mild, moderate, and severe forms, with the severity depending on the symptoms and the response of the ovaries.

Symptoms

Symptoms of OHSS can range from mild to severe and may include:

  • Abdominal bloating or discomfort
  • Nausea and vomiting
  • Rapid weight gain
  • Severe abdominal pain
  • Decreased urinary frequency
  • Shortness of breath
  • Tight or enlarged abdomen

In severe cases, OHSS can lead to more serious complications such as renal failure, thromboembolism (blood clots), and fluid accumulation in the abdomen or chest.

Causes

The exact cause of OHSS is not fully understood, but it is believed to be related to the administration of fertility medications that stimulate the ovaries. Women with Polycystic Ovary Syndrome (PCOS) and younger women tend to be at a higher risk of developing OHSS.

Treatment

Treatment for OHSS varies depending on the severity of the condition. Mild cases may only require monitoring and conservative management, including rest and increased fluid intake. Moderate to severe cases may require more intensive treatment, such as:

  • Hospitalization for monitoring
  • Intravenous fluids to prevent dehydration
  • Medications to alleviate symptoms
  • Paracentesis to remove excess fluid from the abdomen

Prevention

Prevention of OHSS involves careful monitoring of the woman's response to fertility medications and adjusting the dosage as necessary. In some cases, the use of a GnRH antagonist protocol or the administration of a lower dose of hCG can reduce the risk of developing OHSS.

Conclusion

OHSS is a potentially serious complication of fertility treatments that can cause a range of symptoms from mild discomfort to life-threatening conditions. Early recognition and appropriate management are crucial to prevent severe outcomes. Women undergoing fertility treatments should be closely monitored by their healthcare providers for any signs of OHSS.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.